The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can't take or don't respond to migraine medications currently on the market.
from CNN.com - RSS Channel - App International Edition https://ift.tt/3728sWh
via IFTTT
Subscribe to:
Post Comments (Atom)
-
England players will be advised not to jump over advertising hoardings after Jordan Henderson suffered a freak injury. from BBC News https...
-
Weeks after former Melbourne FC chief Paul Guerra launched Federal Court action against the Demons, the club has hit back, lodging its state...
-
Chris Fagan’s 10 years as senior coach have transformed not simply the Brisbane Lions, but the clubs’ conception of what matters in coaching...
No comments:
Post a Comment